Skip to content

Efficacy of Myo-inositol on microinjection

The effect of Myo-inositoon ovarian response changes in microinjection

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180417039338N1
Enrollment
90
Registered
2018-06-05
Start date
2018-08-23
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility. Female infertility

Interventions

Intervention 1: Intervention group: Inofolic compound (200 micrograms of folic acid and 2 grams of inositol) twice a day for three months. Intervention 2: Control group: 1Mg of folic acid.

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Women aged 20-40 years with Polycystic ovary syndrome with oligomenorrhea cycles FSH levels <10 no hormonal treatment during the last 6 months

Exclusion criteria

Exclusion criteria: with endometriosis History of oophorectomy Age over 40 and under 20 years women with infertility due to male factor BMI 30 Endocrine diseases such as hyperprolactinemia, thyroid dysfunction, adrenal insufficiency and Cushing's disease

Design outcomes

Primary

MeasureTime frame
Number of Oocytes. Timepoint: On the oocyte collection day. Method of measurement: Using ovulation test kits.;Oocyte quality. Timepoint: On the oocyte collection day. Method of measurement: Morphologic assesment with microscope.

Secondary

MeasureTime frame
Number of embryos. Timepoint: 2 or 3 days after oocyte collection. Method of measurement: Morphologic assesment with microscope.;Embryo quality. Timepoint: 2 or 3 days after oocyte collection. Method of measurement: Morphologic assesment with microscope.;Fertilization rate. Timepoint: 2 or 3 days after oocyte collection. Method of measurement: (embros number/injected oocytes numbers) * 100.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Alameh Yosefnejad

Babol University of Medical Sciences

zahra_basirat@yahoo.com+98 11 3223 8284

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026